And They're Off: Amylin And Novo Nordisk Begin Their Battle Source: Forbes Saturday 28th January, 2012
Image via Wikipedia Nearly two years after the FDA issued what became the first of two rejections, the agency has finally approved the Bydureon diabetes treatment, setting up what is going to be heated battle between Amylin Pharmaceuticals and ...
